Novoron Bioscience: Remyelination Research

In the past, our co-founder, Brett Drummond, and MStranslate partner, Dr Travis Stiles, have talked broadly about developments in remyelination research around the world.  However, they have never really talked in detail about Travis’ company, Novoron Bioscience, and the work they are pursuing to develop a myelin repair therapy for multiple sclerosis.

To correct this, they sat down recently and recorded this very discussion for the MStranslate community.  In parallel, they discussed the challenges faced in past unsuccessful remyelination research trials, and explored some of Travis’ philosophies on how studies in this field should be conducted.

This discussion can be watched in full below.

As always, If you have any questions on remyelination in multiple sclerosis, or the specific avenues of research being progressed by Novoron Bioscience, please either comment below, join the conversation on our social channels or email them to Brett directly at brett@mstranslate.com.au.

Join the conversation on all things related to multiple sclerosis research by connecting with us on social media. You can find us on Facebook, Twitter, YouTube, Instagram and LinkedIn.

Revisit Travis’ past contributions to MStranslate by clicking here.